Skip to content
Kalpvruksh Markets
Offline Log in

CORONANSEOffline

CORONA Remedies · INE02ZQ01018 · Small Cap · #573
2,379.80−26.00 (−1.08%)last close · 05 Nov 2026
Prev close
2,405.80
Open
—
High
—
Low
—
Volume
—
Mkt cap (6-mo avg)
₹9,911 cr
52-week range · to 05 Nov 20261,347.72,405.8

Loading minute bars…

NSE 1-minute bars from our CandleApi gateway (history from 21 Jul 2026); longer timeframes are built from them. Prices not adjusted for corporate actions.

CORONA is 1% below its 52-week high, above its 200-day average — a Small Cap company, #573 by market cap.NSE prices to 05 Nov 2026 · a description of the data, not advice

Overview

What the data says, line by line

A description, never a buy or sell word · tap a line for its detail

  • above its 20 / 50 / 200-day averages · 1% below its 52-week high
  • +16.0% vs Nifty 500
  • traded value 4.1× usual · delivery 46% vs 52% usual
  • FPI +0.6 pp · DII +3.6 pp · MF schemes in Sept 2026: 16 bought, 7 cut · no promoter pledge · quarter ended 2026-09-30
  • nothing scheduled or restricting

How big is it?

six-month average market cap

Market capitalisation
₹9,911 cr
Rank
#573
Cap band
Small Cap
Nearest cut-off — Mid / Small
−71.01% from ₹34,190 cr
Clear of the cut-off

Our own six-month average, computed the way AMFI computes it; the published classification is on the market cap page.

Did buyers take delivery?

latest session · 2026-11-05

vs its own normal
1.8×
median 13,807
Delivered
24,460
Of volume
53%

Price & trend

Returns

to 05 Nov 2026

PeriodStockvs Nifty 500vs its industry
1 week+7.3%+1.4 pts—
1 month+16.8%+11.6 pts—
3 months+13.5%+16.0 pts—
6 months+36.3%+35.8 pts—
1 year———

Points = the stock’s return minus the benchmark’s. Prices adjusted for splits and bonuses.

Averages & movement

vs 20-day average
+12.6%
above
vs 50-day average
+12.6%
above
vs 200-day average
+29.3%
above
ATR (14)
4.1%
typical daily range
Volatility
38%
1 month, annualised
Beta
0.73
vs Nifty 500, 1 year
Traded value
4.1×
vs usual
Delivery
46%
usual 52%
From the 52-week high
−1.1%
place in range 98% (0 = at the low)

Ownership

Who owns the company

% of all shares, by quarter

GroupDec 25Mar 26Jun 26Sep 26
Promoters69.0%69.0%69.0%69.0%
FPI1.8%2.3% +0.43.6% +1.44.2% +0.6
Mutual funds6.4%6.3%12.5% +6.216.1% +3.6
Other DII0.4%0.7% +0.30.4% −0.30.4%
Individuals1.4%0.8% −0.60.9% +0.11.0% +0.1
Others21.0%21.0% −0.113.6% −7.49.3% −4.3

From the company’s quarterly shareholding pattern. Changes in percentage points against the quarter before. No quarters are on record between Sep 2022 and Jun 2025.

Promoter pledge

Sep 26

Of promoters’ holding
none
Of all shares
none
Dec 25 noneMar 26 noneJun 26 noneSep 26 none

Holders

Sep 26

All shareholders
21,098
Individuals
20,265

Indian passive funds’ stake

2026-06-30

Of free float
0.09%
Of all shares
0.03%
Schemes
9
Days to unwind
0.5
at 100% of volume

17,415 shares held by Indian passive mutual-fund schemes. A floor, not the total — foreign ETFs, insurance and EPFO are not counted.

Which funds bought and sold

mutual funds · quarter ended 2026-06-30

Funds holding
43
9 index · 34 active
Bought more
18
Sold some
2
FundSharesChangeDid
WOC Flexi Cap Fund-Reg(G)Active+1,36,143+279.5%bought
Union Small Cap Fund-Reg(G)Active+1,33,425+177.9%bought
HDFC Pharma and Healthcare Fund-Reg(G)Active+1,02,713+145.4%bought
Axis Business Cycles Fund-Reg(G)Active−12,536−16.1%sold
Axis Equity Savings Fund-Reg(G)Active−473−1.2%sold

Ranked by how much each fund changed its own position, not by size of trade. Every fund here still holds the company — one that sold out entirely leaves no record to find.

Mutual-fund schemes, month by month

fund houses’ own monthly portfolios

MonthSchemesBought newAddedCutSold outShares heldValue
Sep 263810616+32.3%₹1,973 cr
Aug 26344537−1.0%₹1,461 cr
Jul 26370150−0.8%₹1,511 cr
Jun 263781331+92.9%₹1,427 cr
May 26303341+3.9%₹630 cr
Apr 26282743−1.0%₹625 cr

Each month against the one before, counting only the fund houses that reported both (45 houses in Sep 26); a split or bonus is divided out first. “Partial” = fewer than five houses reported yet.

Fund ownership is a quarterly disclosure and counts Indian passive schemes only.

Results

Results

Events & filings

Insider trades

SEBI PIT disclosures filed with NSE

Promoter group
No market buy or sell
Directors & KMP
No market buy or sell
Others
No market buy or sell
Latest 0 of 14 disclosures

None in the latest 50 disclosures — switch to Everyone.

Sums count buys and sells of equity (market and off-market); pledges are listed but not summed. From NSE’s filings: the archive to 2 May 2026, its XBRL filings since (NSE circular NSE/CML/2026/12). A filing describes what was done, not why.

Disclosures & deals

last six months · NSE filings

  • Board outcome
    CORONA Remedies Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
    02 Nov 2026
  • Credit rating
    CORONA Remedies Limited has informed the Exchange about Credit Rating
    01 Oct 2026
  • Board outcome
    CORONA Remedies Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
    03 Aug 2026
  • Bulk deal: BUY
    4,50,868 at ₹1,730 — ABERDEEN ASIAN SMALLER COMPANIES INVESTMENT TRUST PLC
    17 Jun 2026
  • Bulk deal: BUY
    4,62,035 at ₹1,730 — ADITYA BIRLA SUN LIFE MUTUAL FUND
    17 Jun 2026
  • Bulk deal: BUY
    23,33,333 at ₹1,730 — HDFC MUTUAL FUND
    17 Jun 2026
  • Bulk deal: SELL
    43,28,943 at ₹1,730 — SEPIA INVESTMENTS LIMITED
    17 Jun 2026

Latest shown; 8 in six months on all disclosures.

CORONA: only ratings, pledges, insider and takeover disclosures, buybacks, schemes, board outcomes and deals are listed. All deals.

Corporate actions

full published history

0 selected
EarlierDividend₹10Final19 Jun 202619 Jun 2026

1 shown. A falling price on an ex-date is not a loss: a dividend leaves the share as cash and a bonus multiplies the shares held.

Market capitalisation is our own six-month average, computed the way AMFI computes it; the published classification is on the market cap page. Fund ownership is a quarterly disclosure and counts Indian passive schemes only. Nothing here is advice, a recommendation, or a view on the company.